AZR

Azora Therapeutics, Inc.

Stock · NASDAQ

Program summary

FieldValueAs ofSource
Current authorization$430-Jun-2610-Q filed 14-Aug-26
Remaining authorization$4EST30-Jun-2610-Q filed 14-Aug-26
Program expiryn/a—
Repurchased last quarterNot found in filings—
Has used an ASRNo—

Remaining authorization is estimated: we derive it from reported spend, or convert a share authorization at the latest close. Check the linked filings.

Programs

Authorized onAuthorizedRemainingExpiresTerms
12-Aug-26$4$4ESTn/aPurchase Agreement Amendment decreased the Minimum Issuance Price from $4.25 to $4.0010-Q filed 14-Aug-26

Open-market repurchases

None reported in the filings we hold.

Filings through 30-Jun-26